Connect with us

Hi, what are you looking for?

Top Stories

Phillies’ Alvarado Out for Season with Forearm Injury

URGENT UPDATE: The Philadelphia Phillies have confirmed that relief pitcher Jose Alvarado will miss the rest of the 2023 season due to a left forearm strain. Alvarado was placed on the 15-day Injured List as of Friday, marking a significant setback for the team in their playoff push.

In 28 appearances this season, Alvarado recorded a record of 4-2 with a 3.81 ERA over 26 innings. His absence will be felt, especially as he typically played a crucial role as the club’s closer prior to his suspension for performance-enhancing drugs.

Phillies President of Baseball Operations Dave Dombrowski revealed that Alvarado’s positive test, which resulted in an 80-game suspension from May 18 to August 18, was linked to a weight-loss drug he took during the offseason. The suspension has rendered Alvarado ineligible for postseason play, further complicating the Phillies’ strategy as they approach the final stretch of the season.

Manager Rob Thomson described the injury as “pretty mild, but enough to put him on the IL.” He added, “Our plan now is just to get him ready for next year,” signaling a focus on Alvarado’s future recovery rather than immediate returns.

The Phillies bolstered their bullpen by acquiring closer Jhoan Duran from Minnesota at the July 31 trade deadline, and he has stepped up significantly in Alvarado’s absence. With the team in contention for a playoff spot, the pressure will be on Duran to maintain his performance.

Looking ahead, the Phillies have a $9 million club option on Alvarado for the 2026 season, which includes a $500,000 buyout if they opt not to re-sign him. Fans will be watching closely to see how the team navigates this injury while aiming for postseason success.

Stay tuned for more updates as the Philadelphia Phillies continue their campaign amid these challenges.

You May Also Like

Science

The prophecies of the 16th-century French astrologer Nostradamus continue to captivate audiences as we approach 2026. His cryptic insights, compiled in his 1555 publication...

Top Stories

UPDATE: NASA is inviting everyone on Earth to send their name to the Moon aboard the Artemis II mission, set to launch no later...

Top Stories

UPDATE: Authorities have charged 27-year-old Steven Tyler Whitehead with murder following a tragic shooting that critically injured Kimber Mills, a senior cheerleader at Cleveland...

Top Stories

UPDATE: In a stunning turn of events, 18-year-old influencer Piper Rockelle has shattered the previous OnlyFans earnings record set by fellow content creator Sophie...

Top Stories

UPDATE: Pop superstar Ariana Grande is on the road to recovery after testing positive for COVID-19. Her brother, Frankie Grande, shared the encouraging news...

Sports

The UFC event in Abu Dhabi on July 26, 2025, featured a record-breaking performance from Steven Nguyen, who achieved an unprecedented feat by knocking...

Entertainment

**Kat Izzo Defends Relationship with Dale Moss Amid Controversy** Kat Izzo, a contestant from the reality series *Bachelor in Paradise*, publicly affirmed her relationship...

Entertainment

The upcoming Netflix series, Bon Appétit, Your Majesty, is making headlines due to a significant casting change just ten days before filming commenced. Originally...

Top Stories

URGENT UPDATE: Affordable motorcycle helmets under ₹1000 are now available for safety-conscious riders across India. With road safety becoming a pressing issue, these helmets...

Top Stories

UPDATE: Sydney Sweeney’s Baskin-Robbins advertisement is making waves online as backlash intensifies over her recent American Eagle campaign. Just days after critics condemned the...

Top Stories

UPDATE: Chicago Cubs designated hitter Kyle Tucker may have just played his last game for the team as free agency approaches. Following the Cubs’...

Lifestyle

Shares of **Amerant Bancorp** (NYSE:AMTB) received an upgrade from Wall Street Zen on March 10, 2024, transitioning from a hold rating to a buy...

Copyright © All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site.